Epidermal growth factor receptor family in lung cancer and premalignancy.
about
Molecular biology of lung cancer: clinical implicationsEGFR targeted therapy in non-small cell lung cancer: potential role of cetuximabSuccessful treatment of persistent bronchorrhea by gefitinib in a case with Recurrent Bronchioloalveolar Carcinoma: a case reportNew molecularly targeted therapies for lung cancerIndividualized treatment of gastric cancer: Impact of molecular biology and pathohistological featuresAdvances in targeted therapies and new promising targets in esophageal cancerLuciferase fragment complementation imaging in preclinical cancer studiesPhosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFRPathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumThe role of oxidative stress in the biological responses of lung epithelial cells to cigarette smokeIdentification of potent EGFR inhibitors from TCM Database@TaiwanLarge cell carcinoma of the lung – a vanishing entity?RHBDD1 upregulates EGFR via the AP-1 pathway in colorectal cancer.Updates in non-small cell lung cancer--insights from the 2009 45th annual meeting of the American Society of Clinical Oncology.ERBB2 overexpression suppresses stress-induced autophagy and renders ERBB2-induced mammary tumorigenesis independent of monoallelic Becn1 lossLung injury and lung cancer caused by cigarette smoke-induced oxidative stress: Molecular mechanisms and therapeutic opportunities involving the ceramide-generating machinery and epidermal growth factor receptor.Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.A translational approach to lung cancer research: From EGFRs to Wnt and cancer stem cells.Gastrin-releasing peptide receptor mediates activation of the epidermal growth factor receptor in lung cancer cellsRB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.Comparison of droplet digital PCR and conventional quantitative PCR for measuring EGFR gene mutation.Epidermal growth factor receptor exposed to cigarette smoke is aberrantly activated and undergoes perinuclear trafficking.A benzimidazole derivative exhibiting antitumor activity blocks EGFR and HER2 activity and upregulates DR5 in breast cancer cellsLung adenocarcinoma harboring mutations in the ERBB2 kinase domain.Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathwaysKras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal.Targeted therapies for lung cancer: clinical experience and novel agentsMolecular pathology of non-small-cell lung cancer.Virtual screening of natural compounds as inhibitors of EGFR 696-1022 T790M associated with non-small cell lung cancerIdentification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing.Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study.Gastric cancer and trastuzumab: first biologic therapy in gastric cancer.Inhibition of epidermal growth factor receptor signalling reduces hypercalcaemia induced by human lung squamous-cell carcinoma in athymic mice.Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA).EGFR mutation status in tumour-derived DNA from pleural effusion fluid is a practical basis for predicting the response to gefitinib.Mutations in the epidermal growth factor receptor gene are linked to smoking-independent, lung adenocarcinoma.Imaging characteristics of stage I non-small cell lung cancer on CT and FDG-PET: relationship with epidermal growth factor receptor protein expression status and survival.Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer.Heme oxygenase-1 prevents airway mucus hypersecretion induced by cigarette smoke in rodents and humans.Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.
P2860
Q24610335-980EF475-B1EB-4AF9-B562-56F909FB9C2DQ24652337-7ED3F809-83CA-4841-8EC5-20AF03A79E8CQ24673751-E69F557A-9C16-4996-9469-43ECC82FBA02Q24680988-E03209BD-AA5D-4C55-B494-9ABE4C27BA88Q26776198-6EEB074C-9B83-4624-8571-A628B4B3C66EQ26825957-C59A8137-C521-4559-BF4F-713F66AE71A6Q26851635-3F33C987-0794-49D2-BF7F-456C9B70034BQ27851872-7BC40215-9A7A-4239-9418-67585B11E322Q28073129-5693E6B5-CC22-4E2A-9DDD-0E61A507A0E7Q28252074-F5824AA6-D36F-45ED-B82F-40D9EE3EE0A4Q28477481-136B34AE-9EB1-4071-8E79-9A15FFE9B713Q29040247-817F90A3-4EA0-4AA1-82CD-1546485E409CQ33648830-CD87011A-B3E6-4A16-8EEF-FC2F1EC80014Q33875268-15A61B19-9C7E-4AA6-A2D7-F8A666A5115AQ33878879-643E1452-960C-4DCC-A478-3778D7D14101Q34432733-70397E1F-9C3E-4CEF-A040-3145182DFFA4Q34513406-1A3A6E35-ED42-456D-B7DE-F710B4E85004Q34733314-6DE09F4B-F0C3-4E95-9CF9-9980E119720FQ34768400-15FEE254-8EA2-42BC-A832-7E0FF739D956Q34935948-6A41D74D-342C-4A5C-9AC4-624767E545CBQ35159562-2BB1D4D6-F4C3-458B-A25B-14065BE965C7Q35207808-0A16D032-FDCA-4A60-B72E-0913198EB12DQ35274443-1A07A3A9-78E7-4181-8950-3C3A1C66F633Q35790212-2A390508-DDFB-4F40-B16D-A4B294CFB088Q35843403-E19F906B-52EB-481C-8DA7-AB2A1F0D4AF2Q35920623-7C8DE3CE-772B-4087-9EE0-10A2EB6FDC25Q36054970-B8C28808-64AB-427E-9812-8C73653E7A13Q36155104-03ED1595-F997-4537-A1C9-D042E100112EQ36307943-519246DF-3CBD-4086-8E68-274B28591C54Q36401981-5EB1693C-E85C-4B5D-904A-81E11EBE6CC6Q36407059-DDA11720-561C-47DD-9569-29F607BD8E27Q36567393-360B45E7-5D6E-4CEE-A48A-06E68FDE2DCFQ36610803-EBE12446-3BA3-49D1-AE94-1057191ED7C7Q36611204-A8B5DD91-A4BB-48C3-82B8-3032CEAB2425Q36611944-201B7488-E945-489B-8720-16306BB3EC9DQ36615150-2B286844-0080-4513-9A7E-4D1F3B0D0691Q36662662-91A90BE0-7A1C-4934-A5AA-3EA32E113AF5Q36695371-E5B81E1B-998A-4051-B7FA-4AD3B42F5F7BQ36891496-51B4338E-A23D-47C4-9A59-4299930ED70BQ37177513-BA8A1E2C-994F-4040-94FC-3F7BA44BEF67
P2860
Epidermal growth factor receptor family in lung cancer and premalignancy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Epidermal growth factor receptor family in lung cancer and premalignancy.
@ast
Epidermal growth factor receptor family in lung cancer and premalignancy.
@en
Epidermal growth factor receptor family in lung cancer and premalignancy.
@nl
type
label
Epidermal growth factor receptor family in lung cancer and premalignancy.
@ast
Epidermal growth factor receptor family in lung cancer and premalignancy.
@en
Epidermal growth factor receptor family in lung cancer and premalignancy.
@nl
prefLabel
Epidermal growth factor receptor family in lung cancer and premalignancy.
@ast
Epidermal growth factor receptor family in lung cancer and premalignancy.
@en
Epidermal growth factor receptor family in lung cancer and premalignancy.
@nl
P2093
P356
P1433
P1476
Epidermal growth factor receptor family in lung cancer and premalignancy.
@en
P2093
Barbara A Helfrich
Fred R Hirsch
Paul A Bunn
Robert Veve
Wilbur A Franklin
P356
10.1053/SONC.2002.31520
P433
P577
2002-02-01T00:00:00Z